MUC1 and neoplasm: Some of these new vaccine constructs have focused on glycosylated MUC1 B‐cell epitopes, which have elicited robust IgG antibody responses in MUC1.Tg mice that were able to kill MUC1‐bearing tumor cells by CDC and ADCC.95, 96